Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lim, Su Yin
Lee, Jenny H.
Welsh, Sarah J.
Ahn, Seong Beom
Carlino, Matteo S.
Menzies, Alexander M.
Kefford, Richard F.
Scolyer, Richard A.
Long, Georgina V.
Funding for this research was provided by:
National Health and Medical Research Council (1093017, 1130423)
Cure Cancer Australia Foundation (1123911)